5-bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
CAS No.:
Cat. No.: SC23513
Available on Request
Price on Request
Contact us for pricing, MOQ, and lead time
Product Name :5-bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Cat. No.: :SC23513
Purity / Specification :—
CAS No. :652148-98-6
MDL No. :MFCD09952048
Molecular Formula :C11H15BBrNO2
LogP :2.14
Molecular Weight :283.96
TPSA :31.4
Category :Building Blocks
HSN Code :—
SMILES Code :CC1(C)OB(c2ccc(Br)cn2)OC1(C)C
Melting Point :—
InChI Key : :IEIMZGXYHAJOOT-UHFFFAOYSA-N
Boiling Point :No data available
Application Note
AI GeneratedGenerated by AI. Verify before use in regulatory documents.
Lipinski & ADMET Properties
Computational estimateLipinski Rule of 5
iMW ≤ 500 Da✓ 284.0 Da
LogP ≤ 5✓ 2.14
HBD ≤ 5✓ 0
HBA ≤ 10✓ 3
Max 1 violation allowed for oral bioavailability.
Drug-likeness Score
i89/100
Excellent drug-like profile
Predicted LogP
i2.14log units
Optimal range (0–3)
CNS Permeability
iClark model · J Pharm Sci, 1999
CNS+ likely
TPSA 31.4Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−
Requires experimental confirmation.
⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.
